Study Evaluating Safety Pharmacokinetics and Pharmacodynamics of AUR112 in Patients With Relapsed Advanced Lymphoma
Clinical trial NCT06755450 · RECRUITING
Trial details
- NCT number
- NCT06755450
- Sponsor
- Aurigene Discovery Technologies Limited
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-15
- Primary completion
- 2027-01-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.